Insider Transactions in Q4 2023 at Catalent, Inc. (CTLT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2023
|
Scott Gunther SVP, Quality & Reg. Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-0.83%
|
$9,250
$37.18 P/Share
|
|
Dec 08
2023
|
Scott Gunther SVP, Quality & Reg. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
1,023
+3.28%
|
-
|
|
Dec 08
2023
|
Alessandro Maselli President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-2.14%
|
$71,188
$37.18 P/Share
|
|
Dec 08
2023
|
Alessandro Maselli President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,761
+4.02%
|
-
|
|
Dec 08
2023
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
SELL
Payment of exercise price or tax liability
|
Direct |
367
-0.38%
|
$13,579
$37.18 P/Share
|
|
Dec 08
2023
|
Aristippos Gennadios Group Pres. Pharma & Consumer |
BUY
Grant, award, or other acquisition
|
Direct |
1,505
+1.53%
|
-
|
|
Dec 08
2023
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
SELL
Payment of exercise price or tax liability
|
Direct |
256
-1.15%
|
$9,472
$37.18 P/Share
|
|
Dec 08
2023
|
Ricky Hopson Pres. BioProduct Delivery, CoS |
BUY
Grant, award, or other acquisition
|
Direct |
747
+3.24%
|
-
|
|
Oct 27
2023
|
J Martin Carroll |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+19.94%
|
-
|
|
Oct 27
2023
|
Michael J Barber |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+34.31%
|
-
|
|
Oct 27
2023
|
Madhavan Balachandran Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+20.31%
|
-
|
|
Oct 27
2023
|
Steven Barg |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+47.56%
|
-
|
|
Oct 27
2023
|
Karen Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+22.32%
|
-
|
|
Oct 27
2023
|
Rosemary A Crane Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+22.66%
|
-
|
|
Oct 27
2023
|
Rolf A Classon |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+13.9%
|
-
|
|
Oct 27
2023
|
Frank A Damelio |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+46.73%
|
-
|
|
Oct 27
2023
|
Gregory T Lucier |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+17.82%
|
-
|
|
Oct 27
2023
|
Christa Kreuzburg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,245
-6.21%
|
$48,555
$39.32 P/Share
|
|
Oct 27
2023
|
Christa Kreuzburg Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+25.86%
|
-
|
|
Oct 27
2023
|
Jack L Stahl |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+13.9%
|
-
|
|
Oct 27
2023
|
Donald E Morel Jr |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+9.65%
|
-
|
|
Oct 27
2023
|
Michelle R Ryan |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+43.8%
|
-
|
|
Oct 27
2023
|
Stephanie Okey |
BUY
Grant, award, or other acquisition
|
Direct |
6,993
+46.73%
|
-
|
|
Oct 17
2023
|
Joseph Anthony Ferraro SVP, General Counsel, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
2,708
+25.64%
|
-
|
|
Oct 16
2023
|
Patricia Hunt Pres. Consumer Health Div |
SELL
Payment of exercise price or tax liability
|
Direct |
22
-0.19%
|
$1,012
$46.52 P/Share
|